Preferred Label : Binimetinib/Encorafenib Regimen;
NCIt synonyms : Binimetinib/Encorafenib; Encorafenib/Binimetinib; Encorafenib/Binimetinib Regimen; Encorafenib Plus Binimetinib; Encorafenib-Binimetinib; Encorafenib Binimetinib; Braftovi/Mektovi; Encorafenib-Binimetinib Regimen;
NCIt related terms : Binimetinib and Encorafenib;
NCIt definition : A regimen consisting of binimetinib and encorafenib that can be used for the treatment
of melanoma and non-small cell lung cancer (NSCLC).;
NCI Metathesaurus CUI : CL555217;
Codes from synonyms : 25829;
Origin ID : C154326;
UMLS CUI : C4724519;
Semantic type(s)
- chemotherapy_regimen_has_component
- concept_is_in_subset
https://www.has-sante.fr/jcms/p_3561108/fr/mektovi-binimetinib-melanome
2024
false
false
false
France
insurance, health, reimbursement
treatment outcome
binimetinib
Product containing only binimetinib in oral dose form (medicinal product form)
adult
antineoplastic combined chemotherapy protocols
Binimetinib/Encorafenib Regimen
protein kinase inhibitors
evaluation of the transparency committee
melanoma
binimetinib
---
